Is COVID-19 Infection a Death Sentence in Patients Living with Haematological Malignancies? A Case Series
The year 2020 saw the rise of an influenza-like illness from SARS-nCoV2 (Severe Acute Respiratory Illness by novel Coronavirus 2), which causes myriad of symptoms in patients, ranging from mild upper respiratory symptoms to severe ARDS (Acute Respiratory Distress Syndrome). It is, however, known to...
Guardado en:
| Autores principales: | , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Tehran University of Medical Sciences
2021
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/cb9999621ce84dfaa2e4dd43b4b8f522 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:cb9999621ce84dfaa2e4dd43b4b8f522 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:cb9999621ce84dfaa2e4dd43b4b8f5222021-11-20T04:39:28ZIs COVID-19 Infection a Death Sentence in Patients Living with Haematological Malignancies? A Case Series10.18502/aacc.v7i4.76372423-5849https://doaj.org/article/cb9999621ce84dfaa2e4dd43b4b8f5222021-10-01T00:00:00Zhttps://aacc.tums.ac.ir/index.php/aacc/article/view/375https://doaj.org/toc/2423-5849 The year 2020 saw the rise of an influenza-like illness from SARS-nCoV2 (Severe Acute Respiratory Illness by novel Coronavirus 2), which causes myriad of symptoms in patients, ranging from mild upper respiratory symptoms to severe ARDS (Acute Respiratory Distress Syndrome). It is, however, known to cause high morbidity and mortality in patients with underlying comorbidities like diabetes, hypertension, kidney disease, obesity and malignancies. Amongst these, the subset with haematological malignancies has an especially poor prognosis possibly as a result of immune suppression, due to underlying bone marrow depression as well as effects of chemotherapeutic agents. These patients need frequent visits and admissions to the hospital for treatment, thus exposing them to the risk of acquiring the infection. Also, a high index of suspicion, with low threshold for testing is needed in view of possible atypical presentation and symptoms. These patients may also warrant an early ICU admission, as they tend to develop severe disease with ARDS more frequently, with an overall poor prognosis and high mortality rate. We hereby present a series of six patients with underlying haematological malignancies who were admitted in our ICU with a serious COVID-19 illness and a grave outcome. Mudit VarshneyAmandeep JaswalSahil DiwanSantvana KohliRuqaiya BanoHarish C. SachdevaG. UshaTehran University of Medical SciencesarticleChemotherapyCOVID-19SARS-nCoV 2MalignancyHaematological MalignancyMortalityAnesthesiologyRD78.3-87.3Medical emergencies. Critical care. Intensive care. First aidRC86-88.9ENArchives of Anesthesia and Critical Care, Vol 7, Iss 4 (2021) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Chemotherapy COVID-19 SARS-nCoV 2 Malignancy Haematological Malignancy Mortality Anesthesiology RD78.3-87.3 Medical emergencies. Critical care. Intensive care. First aid RC86-88.9 |
| spellingShingle |
Chemotherapy COVID-19 SARS-nCoV 2 Malignancy Haematological Malignancy Mortality Anesthesiology RD78.3-87.3 Medical emergencies. Critical care. Intensive care. First aid RC86-88.9 Mudit Varshney Amandeep Jaswal Sahil Diwan Santvana Kohli Ruqaiya Bano Harish C. Sachdeva G. Usha Is COVID-19 Infection a Death Sentence in Patients Living with Haematological Malignancies? A Case Series |
| description |
The year 2020 saw the rise of an influenza-like illness from SARS-nCoV2 (Severe Acute Respiratory Illness by novel Coronavirus 2), which causes myriad of symptoms in patients, ranging from mild upper respiratory symptoms to severe ARDS (Acute Respiratory Distress Syndrome). It is, however, known to cause high morbidity and mortality in patients with underlying comorbidities like diabetes, hypertension, kidney disease, obesity and malignancies. Amongst these, the subset with haematological malignancies has an especially poor prognosis possibly as a result of immune suppression, due to underlying bone marrow depression as well as effects of chemotherapeutic agents. These patients need frequent visits and admissions to the hospital for treatment, thus exposing them to the risk of acquiring the infection. Also, a high index of suspicion, with low threshold for testing is needed in view of possible atypical presentation and symptoms. These patients may also warrant an early ICU admission, as they tend to develop severe disease with ARDS more frequently, with an overall poor prognosis and high mortality rate.
We hereby present a series of six patients with underlying haematological malignancies who were admitted in our ICU with a serious COVID-19 illness and a grave outcome.
|
| format |
article |
| author |
Mudit Varshney Amandeep Jaswal Sahil Diwan Santvana Kohli Ruqaiya Bano Harish C. Sachdeva G. Usha |
| author_facet |
Mudit Varshney Amandeep Jaswal Sahil Diwan Santvana Kohli Ruqaiya Bano Harish C. Sachdeva G. Usha |
| author_sort |
Mudit Varshney |
| title |
Is COVID-19 Infection a Death Sentence in Patients Living with Haematological Malignancies? A Case Series |
| title_short |
Is COVID-19 Infection a Death Sentence in Patients Living with Haematological Malignancies? A Case Series |
| title_full |
Is COVID-19 Infection a Death Sentence in Patients Living with Haematological Malignancies? A Case Series |
| title_fullStr |
Is COVID-19 Infection a Death Sentence in Patients Living with Haematological Malignancies? A Case Series |
| title_full_unstemmed |
Is COVID-19 Infection a Death Sentence in Patients Living with Haematological Malignancies? A Case Series |
| title_sort |
is covid-19 infection a death sentence in patients living with haematological malignancies? a case series |
| publisher |
Tehran University of Medical Sciences |
| publishDate |
2021 |
| url |
https://doaj.org/article/cb9999621ce84dfaa2e4dd43b4b8f522 |
| work_keys_str_mv |
AT muditvarshney iscovid19infectionadeathsentenceinpatientslivingwithhaematologicalmalignanciesacaseseries AT amandeepjaswal iscovid19infectionadeathsentenceinpatientslivingwithhaematologicalmalignanciesacaseseries AT sahildiwan iscovid19infectionadeathsentenceinpatientslivingwithhaematologicalmalignanciesacaseseries AT santvanakohli iscovid19infectionadeathsentenceinpatientslivingwithhaematologicalmalignanciesacaseseries AT ruqaiyabano iscovid19infectionadeathsentenceinpatientslivingwithhaematologicalmalignanciesacaseseries AT harishcsachdeva iscovid19infectionadeathsentenceinpatientslivingwithhaematologicalmalignanciesacaseseries AT gusha iscovid19infectionadeathsentenceinpatientslivingwithhaematologicalmalignanciesacaseseries |
| _version_ |
1718419801803587584 |